The post Parkinson’s In the News appeared first on Parkinson's Action Network.
The following news articles are included for your information only and do not represent the views or policies of PAN.
Research Team Reviews This Year’s Progress and Promise of 2016
Michael J. Fox Foundation | December 28, 2015
After raising more money than any single year prior thanks to our generous Parkinson’s community, The Michael J. Fox Foundation was in the position to fund a record-breaking amount of critical research grants in 2015. When we ultimately find a cure for Parkinson’s, we’ll look back on this past year and remember several key moments that helped us get there.
A (virtual) world without Parkinson’s
UC Irvine News | January 4, 2016
When the 88-year-old gets up from her computer, she may have trouble standing. Her Parkinson’s disease makes it a struggle some days to lift her legs enough to walk. But in Second Life, she dances, rides horses and walks on the beach.
Use of anticholinergic drugs does not increase risk for dementia in Parkinson’s disease patients
Science Daily | January 5, 2016
Contrary to expectations, a study has determined that the cognitive performance of PD patients taking anticholinergic medications did not differ from those who did not.
Podcast: A Tool to Manage Tremor and Isolation
Michael J. Fox Foundation | January 6, 2016
Silicon Valley-based engineer Anupam Pathak has developed a way to help people deal with the sometimes disabling tremors of Parkinson’s to enjoy a meal, a simple yet powerful act. His device is called Liftware, and it’s based on stabilization technology he first studied in graduate school, though initially with a very different focus in mind. [Audio podcast]
Could Data from Smart Devices Tell Us if a Drug Is Working?
Michael J. Fox Foundation | January 7, 2016
The Michael J. Fox Foundation is uniting two of its longtime partners, Cynapsus Therapeutics and Intel Corporation, in a pilot incorporating wearable devices and “big data” approaches into a clinical trial of a drug that may help patients return to “on” (when symptoms are well managed) from an “off” state when medications stop working.